Vallejo-Torres L, Morris S, Kinge J M, Poirier V, Verne J
UCL Clinical Trials Unit, University College London, London WC1E 6BT, UK.
J Public Health (Oxf). 2014 Mar;36(1):140-8. doi: 10.1093/pubmed/fdt032. Epub 2013 Apr 3.
Increasing incidence of and mortality from skin cancer are posing a large financial burden on the NHS in England. Information provided by cost-of-illness (CoI) studies are used in policy making and are particularly useful for measuring the potential savings from averting a case of disease.
We estimate the cost of skin cancer in England, and model future costs up to 2020. We compare two costing approaches (top-down and bottom-up).
We estimate that costs due to skin cancer were in the range of £106-£112 million in 2008. These figures are very closely related to those provided by the Department of Health (estimated to be £104.0 million in 2007-8 and £105.2 million 2008-9). The expected cost per case of malignant melanoma was estimated to be £2607 and £2560, using the bottom-up and top-down approaches, respectively. The mean cost per case of non-melanoma skin cancer was £889 and £1226, respectively. We estimate that the cost to the NHS due to skin cancer will amount to over £180 million in 2020.
Effective prevention of skin cancer might not only reduce a significant burden of disease but it could also save considerable resources to the NHS.
皮肤癌发病率和死亡率的不断上升给英国国民医疗服务体系（NHS）带来了巨大的经济负担。疾病成本（CoI）研究提供的信息被用于政策制定，对于衡量避免一例疾病所带来的潜在节省尤其有用。
我们估算了英国皮肤癌的成本，并对截至2020年的未来成本进行了建模。我们比较了两种成本核算方法（自上而下和自下而上）。
我们估计2008年皮肤癌造成的成本在1.06亿至1.12亿英镑之间。这些数字与卫生部提供的数字非常接近（2007 - 2008年估计为1.04亿英镑，2008 - 2009年为1.052亿英镑）。使用自下而上和自上而下的方法，估计每例恶性黑色素瘤的预期成本分别为2607英镑和2560英镑。每例非黑色素瘤皮肤癌的平均成本分别为889英镑和1226英镑。我们估计到2020年，NHS因皮肤癌产生的成本将超过1.8亿英镑。
有效预防皮肤癌不仅可能减轻重大疾病负担，还可为NHS节省大量资源。
